XML 16 R1.htm IDEA: XBRL DOCUMENT v3.22.4
Document and Entity Information - USD ($)
$ in Billions
12 Months Ended
Dec. 31, 2022
Feb. 17, 2023
Cover [Abstract]    
Document Type 10-K  
Amendment Flag false  
Document Annual Report true  
Document Transition Report false  
Document Period End Date Dec. 31, 2022  
Document Fiscal Year Focus 2022  
Current Fiscal Year End Date --12-31  
Document Fiscal Period Focus FY  
Entity Registrant Name CYTEK BIOSCIENCES, INC.  
Entity Central Index Key 0001831915  
Entity File Number 001-40632  
Entity Tax Identification Number 47-2547526  
Entity Well-known Seasoned Issuer Yes  
Entity Current Reporting Status Yes  
Entity Shell Company false  
Entity Filer Category Large Accelerated Filer  
Entity Interactive Data Current Yes  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Address Address Line1 47215 Lakeview Blvd.  
Entity Address City Or Town Fremont  
Entity Address, State and Province CA  
Entity Incorporation State Country Code DE  
Entity Address Postal Zip Code 94538  
City Area Code 877  
Local Phone Number 922-9835  
ICFR Auditor Attestation Flag true  
Security12b Title Common Stock, par value $0.001 per share  
Trading Symbol CTKB  
Security Exchange Name NASDAQ  
Entity Common Stock, Shares Outstanding   135,430,624
Entity Public Float $ 1.3  
Documents Incorporated by Reference Portions of the Registrant’s Definitive Proxy Statement relating to the Registrant’s 2023 Annual Meeting of Stockholders are incorporated by reference into Part III of this Annual Report on Form 10-K where indicated. Such Definitive Proxy Statement will be filed with the Securities and Exchange Commission within 120 days after the end of the Registrant’s fiscal year ended December 31, 2022  
Entity Voluntary Filers No  
Auditor Name Deloitte & Touche LLP   
Auditor Firm ID 34  
Auditor Location San Jose, California